- Home
- EDTK vs NXL Comparison
EDTK vs NXL Comparison
Compare EDTK & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDTK
- NXL
- Stock Information
- Founded
- EDTK 2013
- NXL 2010
- Country
- EDTK China
- NXL United States
- Employees
- EDTK N/A
- NXL N/A
- Industry
- EDTK Other Consumer Services
- NXL Medical Specialities
- Sector
- EDTK Real Estate
- NXL Health Care
- Exchange
- EDTK Nasdaq
- NXL Nasdaq
- Market Cap
- EDTK 16.7M
- NXL 19.3M
- IPO Year
- EDTK 2020
- NXL 2022
- Fundamental
- Price
- EDTK $1.02
- NXL $1.07
- Analyst Decision
- EDTK
- NXL Strong Buy
- Analyst Count
- EDTK 0
- NXL 1
- Target Price
- EDTK N/A
- NXL $5.00
- AVG Volume (30 Days)
- EDTK 2.4K
- NXL 306.2K
- Earning Date
- EDTK 08-08-2025
- NXL 11-14-2025
- Dividend Yield
- EDTK N/A
- NXL N/A
- EPS Growth
- EDTK N/A
- NXL N/A
- EPS
- EDTK N/A
- NXL N/A
- Revenue
- EDTK $893,690.00
- NXL $156,931.00
- Revenue This Year
- EDTK N/A
- NXL $38.28
- Revenue Next Year
- EDTK N/A
- NXL $185.71
- P/E Ratio
- EDTK N/A
- NXL N/A
- Revenue Growth
- EDTK N/A
- NXL N/A
- 52 Week Low
- EDTK $0.80
- NXL $0.70
- 52 Week High
- EDTK $1.20
- NXL $4.49
- Technical
- Relative Strength Index (RSI)
- EDTK 45.11
- NXL 42.50
- Support Level
- EDTK $0.95
- NXL $0.93
- Resistance Level
- EDTK $1.08
- NXL $1.12
- Average True Range (ATR)
- EDTK 0.04
- NXL 0.12
- MACD
- EDTK -0.01
- NXL -0.04
- Stochastic Oscillator
- EDTK 49.33
- NXL 31.05
About EDTK Skillful Craftsman Education Technology Limited
Skillful Craftsman Education Technology Ltd provides online education and technology services in China. The services comprises of two aspects - Online vocational training and Virtual simulation experimental training. It covers a wide range of subjects, including mechanics, electronics, auto repair and construction. Majority of its revenues are generated from the People's Republic of China.
About NXL Nexalin Technology Inc.
Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.